Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Studies demonstrate that methamphetamine (meth) use is associated with high-risk sexual
behavior among MSM, putting meth-using MSM at extraordinarily high risk for transmitting or
acquiring HIV. This study of intermediate size (60 participants) and length (3 months of
follow-up) will assess the efficacy of mirtazapine in reducing methamphetamine use among
high-risk MSM.
Phase:
Phase 2
Details
Lead Sponsor:
San Francisco Department of Public Health
Collaborators:
National Institute on Drug Abuse (NIDA) Public Health Foundation Enterprises, Inc.